Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Enrolling By Invitation NCT06067893

Low Dose Dexmedetomidine as a Postoperative Pain Adjunct

Conditions: Spinal Fusion, Adolescent Idiopathic Scoliosis

Sex: All
Ages: 10 Years – 21 Years
Healthy volunteers: Yes
Phase: PHASE2
Enrollment: 46
Sponsor: Nichole Doyle

Location: Children's Mercy Hospital Kansas City Missouri

Summary

This randomized controlled trial examines whether the addition of a low-dose dexmedetomidine infusion to our current multimodal pain management plan decreases narcotic consumption and reduces side effects in adolescent patients undergoing posterior spinal fusion for idiopathic scoliosis.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of idiopathic scoliosis * Undergoing a posterior spinal fusion of at least 5 levels with both thoracic and lumbar involvement Exclusion Criteria: * Known allergy to dexmedetomidine or any of the standard medications used intra or post operatively * Patients with a history of chronic pain currently taking opioids, TCA's, Gabapentinoids * Medical contraindications to administration of dexmedetomidine, unstable cardiac status, (prolonged Qtc, life threatening arrhythmias, use of digoxin) * Moya Moya disease

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06067893). StuddyBuddy aggregates publicly available trial information.